Academic Journal

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

التفاصيل البيبلوغرافية
العنوان: BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors
المؤلفون: Kesari, Santosh, Bessudo, Alberto, Gastman, Brian R, Conley, Anthony P, Villaflor, Victoria M, Nabell, Lisle M, Madere, DeLisa, Chacon, Emma, Spencer, Christina, Li, Li, Larson, Christopher, Reid, Tony, Caroen, Scott, Oronsky, Bryan, Stirn, Meaghan, Williams, Jeannie, Barve, Minal A
المصدر: Future Oncology ; volume 18, issue 29, page 3245-3254 ; ISSN 1479-6694 1744-8301
بيانات النشر: Informa UK Limited
سنة النشر: 2022
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.2217/fon-2022-0481
الاتاحة: http://dx.doi.org/10.2217/fon-2022-0481
https://www.tandfonline.com/doi/pdf/10.2217/fon-2022-0481
Rights: http://creativecommons.org/licenses/by-nc-nd/4.0/
رقم الانضمام: edsbas.D0554209
قاعدة البيانات: BASE